Company Search:
Advanced Search
Sponsored Links
Thrombogenics Nv Company Snapshot
Thrombogenics Nv operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Thrombogenics Nv with three other miscellaneous service companies in Europe: Circassia Pharmaceuticals PLC of the United Kingdom (2015 sales of £10.80 million [US$13.28 million] of which 95% was operating-NIOX), Nel ASA of Norway (99.93 million Norwegian Kroner [US$12.26 million] ), and Pharming Group NV which is based in the Netherlands (10.83 million Euro [US$11.89 million] ).

Sales Analysis. During the year ended December of 2015, sales at Thrombogenics Nv were 11.20 million Euro (US$12.29 million). This is a decrease of 18.7% versus 2014, when the company's sales were 13.78 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Thrombogenics Nv
  Stock Performance Chart for Thrombogenics Nv
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 2.87
(Figures in Euro)
1 Week -2.4%   13 Weeks -3.1%  
4 Weeks -10.0%   52 Weeks -20.8%  
Thrombogenics Nv Key Data:
  Ticker: THR Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 11,198,000
(Year Ending Jan 2016).
Employees: 87
  Currency: Euro Market Cap: 103,590,782
  Fiscal Yr Ends: December Shares Outstanding: 36,094,349
  Share Type: ACTIONS ORDINAIRES Closely Held Shares: 5,114,781
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.